Allergen immunotherapy: What can and cannot be mixed?

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 3, 2008, Pages 659-660

  Esch, Robert E ^a  

^a Greer Laboratories   (United States)

Author keywords

allergen cross reactivity; Allergenic extracts; mixing of extracts

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E ANTIBODY; POLLEN EXTRACT;

ALLERGENICITY; ALTERNARIA; ASPERGILLUS; CLADOSPORIUM; CROSS REACTION; EDITORIAL; HUMAN; IMMUNOTHERAPY; PENICILLIUM; PRESCRIPTION; PRIORITY JOURNAL; SHELF LIFE;

ALLERGENS; CROSS REACTIONS; DESENSITIZATION, IMMUNOLOGIC; HUMANS;

EID: 50949088089     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.07.018     Document Type: Editorial

References (6)

1. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology. Allergen immunotherapy: a practice parameter, second update. J Allergy Clin Immunol 120 suppl (2007) S25-S85
2. Weber R.W. Guidelines for using pollen cross-reactivity in formulating allergen immunotherapy. J Allergy Clin Immunol 122 (2008) 219-221
3. Esch R.E. Formulation of therapeutic allergen mixtures: problems associated with the number, proportion, and enzymatic activities of allergens. Arb Paul Ehrlich Institut 93 (2000) 57-61
4. Mari A., and Scala E. Allergenic extracts for specific immunotherapy: to mix or not to mix?. Int Arch Allergy Immunol 141 (2006) 57-60
5. Grier T.J., LeFevre D.M., Duncan E.A., and Esch R.E. Stability of standardized grass, dust mite, cat, and short ragweed extracts after mixing with mold or cockroach extracts. Ann Allergy Asthma Immunol 99 (2007) 151-160
6. American Academy of Allergy, Asthma and Immunology. Support for practicing allergists: extract stability study yields key data. Academy News 12 (2006) 9